Efficacy of Prophylactic Vaginal Progesterone in Prevention of Preterm Delivery in Women With Placenta Previa

NCT03633175 Phase 2 UNKNOWN

This study evaluates the efficacy of prophylactic vaginal progesterone administration in reducing of the episodes of antepartum hemorrhage and subsequent prevention of preterm delivery in women with placenta previa.

Details

Lead sponsor	Ain Shams University
Phase	Phase 2
Status	UNKNOWN
Enrolment	74
Start date	2018-07-05
Completion	2019-08

Conditions

• Placenta Previa

Interventions

• Vaginal progesterone

Primary outcomes

• Incidence of preterm delivery due to severe antepartum hemorrhage. — from 26 weeks till 37 weeks
  Number of patients who delivered before 37 weeks gestational age

Countries

Egypt